Ryschon AM - Search Results

1

Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada.

McFarlane PA, Madan M, Ryschon AM, Tobe S, Schiffrin EL, Padwal RS, Feldman R, Dresser G, Machan L, Sadri H, Cao KN, Pietzsch JB. McFarlane PA, et al. Among authors: ryschon am. J Med Econ. 2025 Dec;28(1):70-80. doi: 10.1080/13696998.2024.2441072. Epub 2024 Dec 19. J Med Econ. 2025. PMID: 39660790 Free article.

2

Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study.

Pietzsch JB, Geisler BP, Garner AM, Ryschon AM, Gray WA, Fujihara M, Schneider PA. Pietzsch JB, et al. Among authors: ryschon am. J Comp Eff Res. 2025 Jan;14(1):e240055. doi: 10.57264/cer-2024-0055. Epub 2024 Dec 2. J Comp Eff Res. 2025. PMID: 39620243 Free PMC article.

3

Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk Trial.

Blackman DJ, Ryschon AM, Barnett S, Garner AM, Forrest JK, Reardon MR, Pietzsch JB. Blackman DJ, et al. Among authors: ryschon am. Eur J Health Econ. 2024 Nov 23. doi: 10.1007/s10198-024-01739-2. Online ahead of print. Eur J Health Econ. 2024. PMID: 39579244

4

Catheter-Based Radiofrequency Renal Denervation in the United States: A Cost-Effectiveness Analysis Based on Contemporary Evidence.

Kandzari DE, Cao KN, Ryschon AM, Sharp ASP, Pietzsch JB. Kandzari DE, et al. Among authors: ryschon am. J Soc Cardiovasc Angiogr Interv. 2024 Aug 13;3(10):102234. doi: 10.1016/j.jscai.2024.102234. eCollection 2024 Oct. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39525984 Free PMC article.

5

Cost-Effectiveness of Radiofrequency Renal Denervation for Uncontrolled Hypertension in Japan.

Kario K, Cao KN, Tanaka Y, Ryschon AM, Pietzsch JB. Kario K, et al. Among authors: ryschon am. J Clin Hypertens (Greenwich). 2024 Dec;26(12):1502-1512. doi: 10.1111/jch.14922. Epub 2024 Nov 6. J Clin Hypertens (Greenwich). 2024. PMID: 39503996 Free PMC article.

6

Cost-effectiveness of TOMAC therapy for medication-refractory restless legs syndrome: an updated analysis based on Extension study data.

Ryschon AM, Roy A, Pietzsch JB. Ryschon AM, et al. J Med Econ. 2024 Jan-Dec;27(1):1320-1327. doi: 10.1080/13696998.2024.2410595. Epub 2024 Oct 9. J Med Econ. 2024. PMID: 39340771 Free article.

7

Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory Analysis.

Ryschon AM, Cao KN, Roy A, Pietzsch JB. Ryschon AM, et al. Neurol Ther. 2023 Dec;12(6):2133-2146. doi: 10.1007/s40120-023-00551-z. Epub 2023 Oct 12. Neurol Ther. 2023. PMID: 37824047 Free PMC article.

8

Cost associated with diverting ostomy after rectal cancer surgery: a transnational analysis.

Geisler BP, Cao KN, Ryschon AM, Alavi K, Komen N, Pietzsch JB. Geisler BP, et al. Among authors: ryschon am. Surg Endosc. 2023 Oct;37(10):7759-7766. doi: 10.1007/s00464-023-10300-w. Epub 2023 Aug 14. Surg Endosc. 2023. PMID: 37580581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters